Leerink Partners Raises Price Target on Cardinal Health (CAH) Following Conference Call
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Leerink Partners Raises Price Target on Cardinal Health (CAH) Following Conference Call
November 3, 2015 8:36 AM EST
UBS reiterated a Buy rating on Cardinal Health (NYSE: CAH), and raise the price target to $100.00 (from $97.00), following 1Q16 earnings call. On CAH's F1Q16 earnings call, the company provided some fresh input on the outlook for both brand and generic pricing. Regarding brand drug inflation, the rate in F1Q16 was slightly higher than the prior... More
November 2, 2015 9:28 AM EST
Hutchinson Technology (Nasdaq: HTCH) 104% HIGHER; TDK Corporation and Hutchinson Technology Incorporated (Nasdaq: HTCH) jointly announced that they have entered into a definitive merger agreement under which TDK will acquire all of the outstanding shares of common stock of HTI for base consideration of US$3.62 per share, plus additional consideration of up to US$0.38 per share, depending on the level of cash (subject to certain adjustments) less any outstanding borrowings on HTI's revolving line of credit ("net cash") held by HTI as of... More
November 2, 2015 7:47 AM EST
Cardinal Health (NYSE: CAH) reported Q1 EPS of $1.38, $0.28 better than the analyst estimate of $1.10. Revenue for the quarter came in at $28.1 billion versus the consensus estimate of $27.18 billion.
For earnings history and earnings-related data on Cardinal Health (CAH) click here.
...
More
